Washington, DC – The US Department of Commerce recently announced the affirmative final determinations in the antidumping duty (AD) and countervailing duty (CVD) investigations of imports of glycine from India (AD and CVD), China, (CVD only), and Japan (AD only).
The findings noted that exporters from India and Japan sold glycine at less than fair value in the United States at the following rates:
India – 7.75 to 10.86 percent
Japan – 53.66 to 86.22 percent
Commerce also determined that exporters from India and China received countervailable subsidies at rates of:
India – 3.03 to 6.99 percent
China – 144.01 percent
In 2017, US imports of glycine from China, India, and Japan were valued at an estimated $1.1 million, $6.7 million, and $9.5 million respectively. The values for China include imports from Cambodia, which US Customs and Border Protection determined, in its December 2017 interim measures in an Enforcement and Protection Act duty evasion investigation, were transshipments of Chinese glycine.
The investigations were started at the request of the petitioners GEO Specialty Chemicals, Inc. (Lafayette, IN) and Chattem Chemicals, Inc. (Chattanooga, TN).
The US International Trade Commission (ITC) is currently scheduled to make its final injury determinations on or about June 10, 2019. If the ITC makes affirmative final injury determinations, Commerce will issue AD and CVD orders. If the ITC makes negative final determinations of injury, the investigations will be terminated and no orders will be issued.